| Date Filed | Type | Description |
| 03/03/2023 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 8,716 shares
@ $0
Granted 46,200 shares
@ $0
Paid exercise price by delivering 16,140 shares
@ $45.65, valued at
$736.8k
Granted 83,500 options to buy
@ $45.65, valued at
$3.8M
|
|
| 01/03/2023 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 19,582 shares
@ $45.57, valued at
$892.4k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
5
| KAKKIS EMIL D (President & CEO) has filed a Form 5 on Ultragenyx Pharmaceutical Inc. |
| 10/18/2021 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 853 shares
@ $81, valued at
$69.1k
|
|
| 05/10/2021 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 852 shares
@ $115.71, valued at
$98.6k
|
|
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 15,453 shares
@ $0
Paid exercise price by delivering 16,342 shares
@ $142.47, valued at
$2.3M
Sold 30,000 shares
@ $141.8, valued at
$4.3M
Granted 36,000 options to buy
@ $142.47, valued at
$5.1M
|
|
| 02/03/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 30,000 shares
@ $96.82, valued at
$2.9M
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 30,000 shares
@ $82.63, valued at
$2.5M
|
|
| 07/15/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 40,000 shares
@ $85.35, valued at
$3.4M
|
|
| 06/03/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 1,334 shares
@ $69.38, valued at
$92.6k
|
|
| 05/08/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 852 shares
@ $66.26, valued at
$56.5k
|
|
| 04/21/2020 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 851 shares
@ $58.57, valued at
$49.8k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,435 shares
@ $0 |
|
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 1,327 shares
@ $54.93, valued at
$72.9k
|
|
| 05/22/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 1,414 shares
@ $59.5, valued at
$84.1k
|
|
| 05/07/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,435 shares
@ $0 |
|
| 04/23/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 798 shares
@ $64.43, valued at
$51.4k
|
|
| 04/17/2019 |
4/A
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 20,000 shares
@ $0
Sold 2,890 shares
@ $65.52, valued at
$189.4k
Granted 66,000 options to buy
@ $67.55, valued at
$4.5M
|
|
| 03/04/2019 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 20,000 shares
@ $0
Paid exercise price by delivering 2,802 shares
@ $67.55, valued at
$189.3k
Granted 66,000 options to buy
@ $67.55, valued at
$4.5M
|
|
| 06/04/2018 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 926 shares
@ $73.73, valued at
$68.3k
|
|
| 05/22/2018 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 986 shares
@ $64.79, valued at
$63.9k
|
|
| 04/19/2018 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,429 shares
@ $0 |
|
| 03/05/2018 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 19,500 shares
@ $0
Paid exercise price by delivering 1,114 shares
@ $48.43, valued at
$54k
Granted 94,500 options to buy
@ $48.43, valued at
$4.6M
|
|
| 08/29/2017 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Bought 5,853 shares
@ $52.4, valued at
$306.7k
Bought 1,647 shares
@ $52.96, valued at
$87.2k
|
|
| 06/01/2017 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 1,006 shares
@ $56.61, valued at
$56.9k
|
|
| 05/22/2017 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 1,072 shares
@ $57.47, valued at
$61.6k
|
|
|